Juerg Zimmermann,Bertrand Sutter,Hans Michael Buerger
申请号：
US13238967
公开号：
USRE043932E1
申请日:
2011.09.21
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-yl-methyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula I, which may be used for example for tumour therapy.
